Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis

BACKGROUND/AIMS: We evaluated the efficacy and safety of daclatasvir (DCV) and asunaprevir (ASV) in patients with chronic hepatitis C virus (HCV) infection on hemodialysis. METHODS: We performed a single-arm, multicenter prospective study. Twenty-one chronic hemodialysis patients with HCV infection...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gut Liver
Autori principali: Lee, Byung Seok, Song, Myeong Jun, Kwon, Jung Hyun, Lee, Tae Hee, Jang, Ji Woong, Kim, Seok Hyun, Lee, Sae Hwan, Kim, Hong Soo, Kim, Ji Hoon, Kim, Seok Bae, Ko, Soon Young, Song, Do Seon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Editorial Office of Gut and Liver 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430432/
https://ncbi.nlm.nih.gov/pubmed/30400729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18240
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi